OLANREWAJU, Saheed Adewale (PhD) (1), OMOLE, Segun Michael (PhD) (2), BUSOYE, Abiodun Oluwatosin (M.Sc.) (3), ADENIRAN, Isaac Ayobami (PhD) (4), EGBINADE Joshua Oluwafemi (5), AYINDE Abayomi Oluwasegun (PhD in view) (6)
HIV/TB co-infection presents a complex and challenging public health issue globally, particularly in resource-limited settings such as Nigeria. The intersection of these two diseases has profound implications for healthcare systems, as co-infected individuals often experience poorer health outcomes and face increased mortality rates compared to those with either infection alone. Understanding the prevalence, treatment outcomes, and determinants of HIV/TB co-infection is essential for informing targeted interventions and improving patient care.
Corbett, C. E. (2003). HIV-TB Co-infection: Epidemiology, Diagnosis and Management. Indian Journal of Medical Research, 121(4), 480-495.
Ejikeme, N., & Peter, G. A. (2010). Prevalence of Mycobacterium Tuberculosis and Human Immunodeficiency Virus (HIV) Infections in Umuahia, Abia State, Nigeria. African Journal of Microbiology Research, 4(14), 1486-1490.
Federal Ministry of Health. (2000). Tuberculosis and Leprosy Control Efforts in Nigeria. National Tuberculosis and Leprosy Control Programme (NTBLCP), 150.
Griffith, D., & Kerr, C. (1996). Tuberculosis: Disease of the Past, Disease of the Present. Journal of Perianesthesia Nursing, 11(4), 240–5.
Harries, A. D. (1990). Tuberculosis and HIV Infection in Developing Countries. The Lancet, 1, 387-390.
Idigbe, E. O., Nasidi, A., Anyiwo, C. E., Onubogu, C., Alabi, S., Okoye, R., Ugwu, O., & John E. K. (1994). Prevalence of Human Immunodeficiency Virus Antibodies in Tuberculosis Patients in Lagos, Nigeria. Journal of Tropical Medicine and Hygiene, 97(2), 91-97.
International Union Against Tuberculosis and Lung Disease (IUATLD). (2000). TB and HIV in: Management of TB, A Guide for Low-Income Countries, 15th Ed., 12.
Knoll, B., Lassmann, B., & Temesgen, Z. (2007). Current Status of HIV Infection: A Review for Non-HIV Treating Physicians. International Journal of Dermatology, 46(12), 1219–1228.
Olaniran, O., Hassan-Olajokun, R. E., Oyovwevotu, M. A., & Agunlejika, R. A. (2011). Prevalence of Tuberculosis among HIV/AIDS Patients in Obafemi Awolowo University Teaching Hospital Complex OAUTHC, ILE – IFE. International Journal of Biological and Medical Research, 2(4), 874-877.
Okodua, M. A., Nwobu, G. O., Tatfeng, Y. M., Ongey, J. Y., & Agwu, E. (2004). Incidence of HIV-Related Pulmonary Tuberculosis in Edo State, Nigeria. Shiraz E-Medical Journal, 5(1), 10–15.
Onipede, A. O., Idigbe, O., Ako-Nai, A. K., Omojola, O., Oyelese, A. O., Aboderin, A. O., Komolafe, A. O., & Wemambu, S. N. C. (1999). Seroprevalence of HIV Antibodies in TB Patients in Ile-Ife. East African Medical Journal, 76(3), 127-132.
Rothenberg, R. B., Scarlett, M., del Rio, C., Reznik, D., & O'Daniels, C. (1998). Oral Transmission of HIV. AIDS, 12(16), 2095–2105.
Salami, A. K., & Katibi, I. A. (2006). Human Immunodeficiency Virus Associated Tuberculosis: Pattern and Trend in the University of Ilorin Teaching Hospital. African Journal of Medical Sciences, 2, 12-15.
Silvero, A. M., Acevedo-Gadea, C. R., & Pantanowitz, L. (2009). Unsuspected Parvovirus B19 Infection in a Person with AIDS. The AIDS Reader, 19(6), 121-124.
World Health Organization. (2006). Global Tuberculosis Control – Surveillance, Planning, Financing. WHO Report 2006.
World Health Organization. (2007). Male Circumcision: Global Trends and Determinants of Prevalence, Safety and Acceptability, 1-30.
World Health Organization. (2008). WHO Report 2008: Global Tuberculosis Control. Retrieved from http://www.who.int/tb/publications/global_report/2008/annex_3/en/index.html
World Health Organization. (2010). Tuberculosis Fact sheet N°104. Retrieved from http://www.who.int/mediacentre/factsheets/fs104/en/index.html